CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory of $0 as of 2023-01-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory · last filed 2026-02-18
- 2023-01-27: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $0.00.
- 2022-04-05: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $0.00.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory |
|---|---|
| 2023-01-27 | $0.00 10-K · filed 2026-02-18 |
| 2022-04-05 | $0.00 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |